about
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EP...
Read More
13.70
-0.54
(-3.79%)
937.0K
XNAS Volume
High volume today
XNAS 06 Aug, 2026 3:54 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
DBV Tech (ADR) Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..